stock price decline

Vistagen's failed drug trial caused 81% stock drop. Securities lawsuit filed for investors who bought shares April 2024-December 2025. Lead plaintiff deadline: March 16, 2026.

Bath and Body Works faces securities lawsuit alleging false statements about business strategy. Stock dropped 24.8% after missing Q3 guidance with declining revenue and net income.

Inovio Pharmaceuticals faces securities lawsuit over false statements about manufacturing and regulatory prospects. FDA rejected accelerated approval for lead drug candidate, causing 24% stock drop.

Law firm investigates Ramaco Resources for alleged securities fraud over inactive Wyoming mine despite reported groundbreaking. Class action deadline: March 31, 2026.

Law firm investigates Ralliant for potential securities violations after $1.4B goodwill impairment announcement causes 31.8% stock decline, questioning disclosure timing and accuracy.

Robbins LLP files class action against Paysafe Limited for alleged misrepresentations about client risk and financial guidance. Stock fell 27.6% in November 2025.

Law firm seeks lead plaintiffs for class actions against Ramaco Resources and Beyond Meat over alleged misrepresentations. Deadlines are March 31 and March 24, 2026.

Law firm Kaskela LLC investigates BARK Inc. over 60% stock decline, examining whether leadership violated securities laws or breached fiduciary duties to shareholders.

Law firm investigates Danone for securities fraud over contaminated infant formula from Thailand. Stock fell nearly 11% following disclosure of toxic bacterial contamination in formula batches.